| 1 |
Li K, Wu J, Wu F, et al. The clinical and chest CT features associated with severe and critical COVID-19 pneumonia[J]. Invest Radiol, 2020, 55(6): 327-331.
|
| 2 |
Torres A, Chalmers JD, Dela CC, et al. Challenges in severe community-acquired pneumonia: a point-of-view review[J]. Intensive Care Med, 2019, 45(2): 159-171.
|
| 3 |
Aoyagi Y, Ohashi M, Funahashi R, et al. Oropharyngeal dysphagia and aspiration pneumonia following coronavirus disease 2019: A case report[J]. Dysphagia, 2020, 35(4): 545-548.
|
| 4 |
刘九玉，赵 磊，段文超. 中性粒细胞/淋巴细胞比值对重症肺炎病情严重程度及预后的评估价值[J]. 中国医药科学，2021, 11(5): 15-18, 23.
|
| 5 |
许绍珍，李学兵，孙宗发，等. 中性粒细胞/淋巴细胞和降钙素原检测重症肺炎患者的临床意义[J/CD]. 中华肺部疾病杂志(电子版), 2021, 14(3): 312-314.
|
| 6 |
杨 帆，孔德华，王见斌，等. 动脉血乳酸，乳酸清除率与重症肺炎机械通气患者APACHEⅡ评分及预后的相关性[J]. 河北医药，2021, 43(5): 740-743.
|
| 7 |
中国医师协会急诊医师分会. 中国急诊SP临床实践专家共识[J]. 中国急救医学，2016, 36(2): 97-107.
|
| 8 |
Gilani MT, Razavi M, Azad AM. A comparison of simplified acute physiology score ii, acute physiology and chronic health evaluation ii and acute physiology and chronic health evaluation iii scoring system in predicting mortality and length of stay at surgical intensive care unit[J]. Niger Med J, 2014, 55(2): 144-147.
|
| 9 |
任红梅，单锡崢. 中性粒细胞与淋巴细胞比值预测重症肺炎患者预后的价值[J]. 临床肺科杂志，2019, 24(2): 275-279.
|
| 10 |
Yin S, Huang M, Li D, et al. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2[J]. J Thromb Thrombolysis, 2021, 51(4): 1107-1110.
|
| 11 |
Karakioulaki M, Stolz D. Biomarkers in pneumonia-beyond procalcitonin[J]. Int J Mol Sci, 2019, 20(8): 26-31.
|
| 12 |
Gharebaghi N, Nejadrahim R, Mousavi SJ, et al. The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial[J]. BMC Infect Dis, 2020, 20(1): 786-792.
|
| 13 |
Lee KL, Lee CM, Yang TL, et al. Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010-2019[J]. J Formos Med Assoc, 2021, 120(1): 281-291.
|
| 14 |
梁 欢，高 烨，苗常青，等. 中性粒细胞/淋巴细胞比值对重症肺炎患者28 d死亡风险的预测价值[J]. 中华危重病急救医学，2019, 31(7): 827-831.
|
| 15 |
邹天雷，姜艳群，何艳春. 血清白细胞介素-10及乳酸水平与重症肺炎患者免疫功能及临床转归的关系[J]. 川北医学院学报，2020, 35(5): 849-852.
|
| 16 |
陈吉威. 重症肺炎患者血清降钙素原、乳酸水平和乳酸清除率的变化及临床意义[J]. 中国基层医药，2018, 25(4): 453-456.
|
| 17 |
李 敏. 重症肺炎患者中性粒细胞/淋巴细胞比值和红细胞分布宽度及其28 d死亡风险的预测价值[J]. 湖南师范大学学报(医学版), 2021, 18(4): 255-258.
|
| 18 |
张允健，唐钰坡，祝金平. 中性粒细胞淋巴细胞比值与老年社区获得性肺炎患者病情严重程度和预后的关系[J]. 医学临床研究，2019, 36(9): 1829-1831.
|
| 19 |
Schöll N, Rohde GGU. [Community-acquired Pneumonia in the Elderly][J]. Pneumologie, 2019, 73(10): 605-616.
|
| 20 |
von Baum H, Ewig S, Marre R, et al. Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia[J]. Clin Infect Dis, 2008, 46(9): 1356-1364.
|
| 21 |
Ma HM, Tang WH, Woo J. Predictors of in-hospital mortality of older patients admitted for community-acquired pneumonia[J]. Age Ageing, 2011, 40(6): 736-741.
|
| 22 |
Janssens JP. Pneumonia in the elderly (geriatric) population[J]. Curr Opin Pulm Med, 2005, 11(3): 226-230.
|
| 23 |
Fung HB, Monteagudo-Chu MO. Community-acquired pneumonia in the elderly[J]. Am J Geriatr Pharmacother, 2010, 8(1): 47-62.
|
| 24 |
Li Y, Wang W, Chen K, et al. Influence of lncRNA NKILA on bloodstream infection of hypervirulent klebsiella pneumoniae and its ability to induce delayed neutrophil apoptosis[J]. Evid Based Complement Alternat Med, 2021, 2021: 6101078.
|
| 25 |
Sebo P, Maisonneuve H, Lourdaux J, et al. Self-reported symptoms in French primary care SARS-CoV-2 patients: association with gender and age group[J]. Fam Pract, 2021, 38(Suppl 1): i37-i44.
|
| 26 |
Han X, Zhou F, Li H, et al. Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia[J]. BMC Infect Dis, 2018, 18(1): 192.
|